NEW YORK (GenomeWeb) – NeoGenomics today reported a 3 percent year-over-year rise in revenues for the first quarter, while clinical testing revenues grew 4 percent.

For the three months ended March 31, the Fort Myers, Florida-based cancer genetic testing firm recorded $61.7 million in total revenues, slightly above the consensus Wall Street estimate of $61.4 million, and up from $59.7 million in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.